From June 21, 2022 until June 23, 2022
At Shanghai - Shanghai New International Expo Centre(SNIEC), Shanghai, China
010-58036296
https://www.cphi.com/china/visit/icse
Categories: Science & Research, Medical & Pharma
Hits: 13636
Where HEalth and Machinery Come Together. Why do business in China? Why should I attend? Caution! CPhI 365 Digital Solutions.
This is part of Informa Markets Division at Informa PLC.
Informa PLC owns this site and all copyright is theirs. Informa PLC is located at 5 Howick Place in London SW1P1WG. Registered in England and Wales. Number 8860726.
CPhI China can help you grow your business in China's 2nd largest pharma country. This is the place to go if you're looking for new business opportunities or market insights.
Find out more.
P-MEC China, Asia's largest marketplace for pharmaceutical machinery & equipment, provides access to over 800 suppliers of pharmaceutical machinery & equipment from China and abroad.
Find out more.
It is the only Asia-only pharma event that covers the entire supply chain. This means you will be able meet suppliers from all areas of the industry.
There will be exhibitors representing every sector, from CRO and Clinical Trials to Manufacturing, Packaging, and Finished Products.
Our SMART event program is a great way to meet new people, source information, and get the help you need to grow your business.
CPhI China is a platform for pharma professionals looking to find the right products and people in the Americas region to transform their businesses and improve their bottom lines.
Here's a quick overview who attends CPhI North America.
International Contract Services Expo (iCSE) China is the international exhibition zone for outsourcing services in the pharmaceutical industry. This zone is the connection between buyers and sellers in the market of pharmaceutical contract services and acts as an international platform for companies and a wide variety of outsourcing services, including clinical trials, IT, research, biotechnological, logistical and analytical services.
The rise of innovative drugs and the sustained growth of global medical expenditure. The emerging CRO & CMO market represented by the Asia-Pacific region is now in a golden period of development, with a compound of more than 20% growth rate per year at the forefront of the world.
iCSE China will provide a unique trade platform for eminent exhibitors and over 70,000 visits from home and abroad to discuss the future of pharmaceutical R&D and outsourced services in CRO & CMO.